NCT06450028View on ClinicalTrials.gov

Lidocaine Versus Bupivacaine in Orthognathic Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 26, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

July 1, 2026

Conditions
Pain, PostoperativeNumbnessTemperature SensationPerception of Touch
Interventions
DRUG

10 cc of 0.25% bupivacaine hydrochloride with 1:200,000 epinephrine

Injection of 10 cc of 0.25% bupivacaine hydrochloride with 1:200,000 epinephrine.

DRUG

6.8 cc of 2% lidocaine hydrochloride with 1:100,000 epinephrine

Injection of 6.8 cc of 2% lidocaine hydrochloride with 1:100,000 epinephrine.

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT06450028 - Lidocaine Versus Bupivacaine in Orthognathic Surgery | Biotech Hunter | Biotech Hunter